Teikoku Seiyaku Co., Ltd.

8 clinical trials · Sponsor

Record	Firm	Date
To Evaluate the Adhesion of TK-254RX on Healthy Participants (NCT07307794)	Teikoku Seiyaku Co., Ltd.	2026-01-19
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains. (NCT06866613)	Teikoku Seiyaku Co., Ltd.	2025-03-31
To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers. (NCT06870422)	Teikoku Seiyaku Co., Ltd.	2025-02-28
Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions (NCT06871046)	Teikoku Seiyaku Co., Ltd.	2025-02-20
To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects (NCT06823284)	Teikoku Seiyaku Co., Ltd.	2025-01-21
Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers. (NCT06042192)	Teikoku Seiyaku Co., Ltd.	2023-09-14
Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain (NCT04908748)	Teikoku Seiyaku Co., Ltd.	2021-05-20
Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain (NCT02729207)	Teikoku Seiyaku Co., Ltd.	2016-07-01

Every clearance here is in the API, with alerts when new ones post.